english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Olaparib (Lynparza°) as "maintenance" therapy for certain advanced ovarian cancers after first-line chemotherapy

Clomifene: serious, sometimes irreversible, vision disorders

Drugs that interfere with the placenta and affect the fetus

European Commission: taken to task by the Ombudsman for lack of transparency

Drugs to avoid in the name of better patient care: 2024 update

Revision of European pharmaceutical legislation

Safety signals: why bother?

Abemaciclib (Verzenios°), palbociclib (Ibrance°) and ribociclib (Kisqali°) added to an aromatase inhibitor in certain breast cancers

When the cause of a disorder is not immediately obvious: could a drug be responsible?

Prescribing cascades: recognise them and take corrective action

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90